capasity and AXR sweating volume. To our knowledge, elevated TEWL and decreased water holding capacity are believed to skin barrier dysfunction. It was surprising that we found positive correlation between TEWL and water holding capacity in AD.
Background: Although the mechanism is uncertain, some studies have linked prenatal and early-life pet exposure to a decreased risk of atopic dermatitis (AD). Methods: 675 participants in a southeast Michigan population-based birth cohort were evaluated at age 2 to 4 years. Based on medical history and examination, a study physician was asked to determine whether there was evidence of current AD or a past history consistent with AD. Information regarding the presence of indoor dogs or cats was prospectively collected from the participants' mothers during pregnancy. Results: Of 675 maternal-child pairs, 255 (37.7%) mothers reported living with a pet during pregnancy and 150 children (22%) were diagnosed with either current or prior atopic dermatitis by age 2 to 4 years. Compared to mothers not exposed to indoor pets during pregnancy, the risk of AD was lower among offspring of 255 mothers that lived with an indoor pet prenatally [OR ¼ 0.6, 95% CI, There did not appear to be a similar effect among 75 mothers with cat only prenatal exposure [OR ¼ 0.9 (0.5, 1.6), P ¼ 0.79]. When analyses were restricted to the presence or absence of dog exposure (not considering cat coexposure), offspring were also less likely to have had current or prior AD [OR 0.5(0.3, 0.8), P ¼ 0.002]. Results of analyses further restricted to dog exposure and "current AD" (AD present at the 2-4 year evaluation) were similar [OR 0.5 (0.3, 0.9), P ¼ 0.013]. These results were not substantially different in logistic regression models adjusting for the child's total IgE level or the presence of atopy as assessed by positive allergen-specific IgE tests or positive skin prick tests to a panel of common allergens. Conclusions: Prenatal dog exposure is associated with a lower risk of AD in young children. The mechanism(s) responsible for this relationship require further study. Background: Economic analyses (EAs) were performed in 5 European countries to determine costs, outcomes and cost-effectiveness of a partially hydrolysed 100% whey-based infant formula (PHF-W) in the prevention of atopic dermatitis (AD) in 'at risk' children when compared to standard cow's milk formula (SF) or extensively hydrolyzed formula (EHF). Methods: The EAs were performed in France, Germany, Spain, Denmark and Switzerland, using decision-analytic models describing AD treatment pathways, as well as resource utilisation and costs associated with the treatment of AD in healthy yet 'at risk' newborns who could not be exclusively breastfed. A time horizon of 12 months including 6 months of formula consumption was applied, with country-specific resource use and costs. In 4 settings, SF was the main comparator. The outcomes of the EAs were the number of avoided cases and the incremental cost per avoided case (ICER) of AD when comparing subjects who used PHF-W versus SF. An ICER represents the additional cost for obtaining each additional clinical outcome gained; in this instance each avoided case. Given a lack of significant differences in efficacy between PHF-W and EHF, a cost-minimization approach was used in all settings to compare them. A negative ICER represents savings. Three perspectives were applied: the Ministry of Health (MOH), the family and society. Results: In the base case analyses selecting PHF-W over SF yielded numbers of avoided cases of AD ranging from 1653 (Switzerland) to 13,356 cases (France) for respective "at risk" birth cohorts of 22,933 and 185,298 infants. The analyses of PHF-W versus SF generated ICERs ranging from €801 to €1343 (MOH), from 2€1796 to 2€454 (family) and from 2€995 to €719 (society). The costs of formula and time loss were the main cost drivers. When comparing PHF-W to EHF in prevention, PHF-W demonstrated savings ranging from €4 to €120 million for society, or €1.3 to €64 million for the MOH perspective. The robustness of the models and the direction of the results were confirmed by one-way and probabilistic sensitivity analyses. Conclusions: In 5 European countries, PHF-W appears to offer a better prevention than SF at a reasonable cost, and at a lower cost than EHF. Hospital General de Rosarito, Tijuana, Mexico. Background: Describe AD prevalence and identify associated risk factors in Mexican children. Methods: Multi-centric, cross-sectional ambiental survey. We applied the standardized Spanish-version ISAAC questionnaire to children's tutors aged 6 to 7 years in 8 Mexican cities. Sampling units randomly selected from local schools with advisable sample size of 3000 questionnaires per centre. Questions to evaluate actual AD: Has your child had itchy rash at any time in the past 12-months? Has this itchy rash at any time affected any of the following places: the folds of the elbows, behind the knees, in front of the ankles, under the buttocks or around the neck, ears or eyes? A risk analysis was made through multivariate logistical regression, central tendency and dispersion measures were obtained with respective 95% confidence intervals.
Prevalence and Associated Risk Factors for Atopic Dermatitis Symptoms in Mexican Children

